tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Thiogenesis Reports Positive Interim Results and Pipeline Advancements
Company AnnouncementsThiogenesis Reports Positive Interim Results and Pipeline Advancements
9h ago
Thiogenesis Therapeutics Advances in MELAS Treatment with TTI-0102 Study
PremiumCompany Announcements
Thiogenesis Therapeutics Advances in MELAS Treatment with TTI-0102 Study
8d ago
TTI
Thiogenesis Therapeutics Advances LSS Treatment with New TTI-0102 Study
PremiumCompany Announcements
Thiogenesis Therapeutics Advances LSS Treatment with New TTI-0102 Study
8d ago
TTI
Thiogenesis Extends Investor Relations Agreement with Capital Analytica
PremiumCompany Announcements
Thiogenesis Extends Investor Relations Agreement with Capital Analytica
1M ago
Thiogenesis Therapeutics Reports AGM Results and Corporate Milestones
PremiumCompany Announcements
Thiogenesis Therapeutics Reports AGM Results and Corporate Milestones
2M ago
Thiogenesis Therapeutics Corp Secures Over C$4.14 Million in Private Placement
PremiumCompany AnnouncementsThiogenesis Therapeutics Corp Secures Over C$4.14 Million in Private Placement
3M ago
Thiogenesis Upsizes Private Placement Amid Strong Demand
Premium
Company Announcements
Thiogenesis Upsizes Private Placement Amid Strong Demand
3M ago
Thiogenesis Therapeutics Announces $1.5 Million Private Placement to Fund Clinical Trials
Premium
Company Announcements
Thiogenesis Therapeutics Announces $1.5 Million Private Placement to Fund Clinical Trials
4M ago
Thiogenesis Advances Pediatric MASH Trial and Secures EU Patent
PremiumCompany Announcements
Thiogenesis Advances Pediatric MASH Trial and Secures EU Patent
4M ago
Thiogenesis to Showcase Promising Mitochondrial Treatments at UMDF Conference
PremiumCompany Announcements
Thiogenesis to Showcase Promising Mitochondrial Treatments at UMDF Conference
5M ago
Thiogenesis Expands Phase 2 MELAS Trial with New French Site
PremiumCompany Announcements
Thiogenesis Expands Phase 2 MELAS Trial with New French Site
5M ago
Thiogenesis Therapeutics Grants Stock Options to Directors
PremiumCompany Announcements
Thiogenesis Therapeutics Grants Stock Options to Directors
5M ago
Thiogenesis Receives FDA Clearance for Phase 2a Trial in Leigh Syndrome
PremiumCompany AnnouncementsThiogenesis Receives FDA Clearance for Phase 2a Trial in Leigh Syndrome
5M ago
Thiogenesis Launches Phase 2 Trial for MELAS Treatment
Premium
Company Announcements
Thiogenesis Launches Phase 2 Trial for MELAS Treatment
6M ago
Thiogenesis Expands European Reach with New Consultancy Agreement
Premium
Company Announcements
Thiogenesis Expands European Reach with New Consultancy Agreement
9M ago
Thiogenesis Therapeutics Begins OTCQX Trading and Prepares for Phase 2 Trial
PremiumCompany Announcements
Thiogenesis Therapeutics Begins OTCQX Trading and Prepares for Phase 2 Trial
9M ago
Thiogenesis to Launch Phase 2 Trial for MELAS Treatment
PremiumCompany Announcements
Thiogenesis to Launch Phase 2 Trial for MELAS Treatment
9M ago
Thiogenesis Therapeutics Advances in Mitochondrial Disease Trials
PremiumCompany Announcements
Thiogenesis Therapeutics Advances in Mitochondrial Disease Trials
11M ago
TTI
Thiogenesis Gains DTC Eligibility and Expands U.S. Presence
PremiumCompany Announcements
Thiogenesis Gains DTC Eligibility and Expands U.S. Presence
11M ago
TTI
Thiogenesis Secures Key European Patent
PremiumCompany AnnouncementsThiogenesis Secures Key European Patent
1y ago
TTI
Thiogenesis Boosts Investor Relations with New Partnership
Premium
Company Announcements
Thiogenesis Boosts Investor Relations with New Partnership
1y ago
TTI
Thiogenesis Discusses Breakthrough Treatment at Symposium
Premium
Company Announcements
Thiogenesis Discusses Breakthrough Treatment at Symposium
1y ago
TTI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >